Sign Out
Each mL of solution for injection/infusion contains 50 mg idarucizumab.
Each vial contains 2.5 g idarucizumab in 50 mL.
Idarucizumab is produced by recombinant DNA technology in Chinese Hamster Ovary cells.
Excipients with known effect: Each 50 mL vial contains 2 g sorbitol and 25 mg sodium.
Excipients/Inactive Ingredients: sodium acetate trihydrate, acetic acid, sorbitol, polysorbate 20, water for injection.
Continue with Google